BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10879734)

  • 1. Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast.
    Jones C; Foschini MP; Chaggar R; Lu YJ; Wells D; Shipley JM; Eusebi V; Lakhani SR
    Lab Invest; 2000 Jun; 80(6):831-6. PubMed ID: 10879734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization.
    Thor AD; Eng C; Devries S; Paterakos M; Watkin WG; Edgerton S; Moore DH; Etzell J; Waldman FM
    Hum Pathol; 2002 Jun; 33(6):628-31. PubMed ID: 12152162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer.
    Bartels S; van Luttikhuizen JL; Christgen M; Mägel L; Luft A; Hänzelmann S; Lehmann U; Schlegelberger B; Leo F; Steinemann D; Kreipe H
    J Pathol; 2018 Jul; 245(3):373-383. PubMed ID: 29708279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant myoepithelioma of soft tissue: a case report with cytogenetic findings.
    Balogh Z; Deák L; Sápi Z
    Cancer Genet Cytogenet; 2008 Jun; 183(2):121-4. PubMed ID: 18503832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal rearrangements in myoepithelial carcinoma of the breast that presented as metachronic double cancer with invasive ductal carcinoma in the ipsilateral breast.
    Kawashima H; Ariizumi T; Saijo Y; Moriyama M; Umezu H; Ikeda Y; Ogose A; Endo N
    Cancer Genet; 2016 Nov; 209(11):501-505. PubMed ID: 27886676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization.
    Gao Y; Niu Y; Wang X; Wei L; Lu S
    J Mol Med (Berl); 2009 Feb; 87(2):145-52. PubMed ID: 18936904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization.
    Gong G; DeVries S; Chew KL; Cha I; Ljung BM; Waldman FM
    Clin Cancer Res; 2001 Aug; 7(8):2410-4. PubMed ID: 11489820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer.
    Aubele MM; Cummings MC; Mattis AE; Zitzelsberger HF; Walch AK; Kremer M; Höfler H; Werner M
    Diagn Mol Pathol; 2000 Mar; 9(1):14-9. PubMed ID: 10718208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization.
    Gronwald J; Jauch A; Cybulski C; Schoell B; Böhm-Steuer B; Lener M; Grabowska E; Górski B; Jakubowska A; Domagała W; Chosia M; Scott RJ; Lubiński J
    Int J Cancer; 2005 Mar; 114(2):230-6. PubMed ID: 15540206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucinous cancers have fewer genomic alterations than more common classes of breast cancer.
    Fujii H; Anbazhagan R; Bornman DM; Garrett ES; Perlman E; Gabrielson E
    Breast Cancer Res Treat; 2002 Dec; 76(3):255-60. PubMed ID: 12462386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization.
    Ghazani AA; Arneson N; Warren K; Pintilie M; Bayani J; Squire JA; Done SJ
    Neoplasia; 2007 Jun; 9(6):511-20. PubMed ID: 17603634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.
    Jones C; Nonni AV; Fulford L; Merrett S; Chaggar R; Eusebi V; Lakhani SR
    Br J Cancer; 2001 Aug; 85(3):422-7. PubMed ID: 11487275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization.
    Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Hutzler P; Höfler H; Werner M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):94-102. PubMed ID: 10214356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas.
    Zudaire I; Odero MD; Caballero C; Valenti C; Martínez-Penuela JM; Isola J; Calasanz MJ
    Histopathology; 2002 Jun; 40(6):547-55. PubMed ID: 12047766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas.
    Simpson PT; Reis-Filho JS; Lambros MB; Jones C; Steele D; Mackay A; Iravani M; Fenwick K; Dexter T; Jones A; Reid L; Da Silva L; Shin SJ; Hardisson D; Ashworth A; Schmitt FC; Palacios J; Lakhani SR
    J Pathol; 2008 Jul; 215(3):231-44. PubMed ID: 18473330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer in young women (< or = 35 years): Genomic aberrations detected by comparative genomic hybridization.
    Weber-Mangal S; Sinn HP; Popp S; Klaes R; Emig R; Bentz M; Mansmann U; Bastert G; Bartram CR; Jauch A
    Int J Cancer; 2003 Nov; 107(4):583-92. PubMed ID: 14520696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic alterations in tubular breast carcinomas.
    Waldman FM; Hwang ES; Etzell J; Eng C; DeVries S; Bennington J; Thor A
    Hum Pathol; 2001 Feb; 32(2):222-6. PubMed ID: 11230710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes.
    Jones C; Ford E; Gillett C; Ryder K; Merrett S; Reis-Filho JS; Fulford LG; Hanby A; Lakhani SR
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5988-97. PubMed ID: 15447982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.